Development and use of health outcome descriptors: a guideline development case study

Background: During healthcare guideline development, panel members often have implicit, different definitions of health outcomes that can lead to misunderstandings about how important these outcomes are and how to balance benefits and harms. McMaster GRADE Centre researchers developed ‘health outcome descriptors’ for standardizing descriptions of health outcomes and overcoming these problems to support the European Commission Initiative on Breast Cancer (ECIBC) Guideline Development Group (GDG). We aimed to determine which aspects of the development, content, and use of health outcome descriptors were valuable to guideline developers. Methods: We developed 24 health outcome descriptors related to breast cancer screening and diagnosis for the European Commission Breast Guideline Development Group (GDG). Eighteen GDG members provided feedback in written format or in interviews. We then evaluated the process and conducted two health utility rating surveys. Results: Feedback from GDG members revealed that health outcome descriptors are probably useful for developing recommendations and improving transparency of guideline methods. Time commitment, methodology training, and need for multidisciplinary expertise throughout development were considered important determinants of the process. Comparison of the two health utility surveys showed a decrease in standard deviation in the second survey across 21 (88%) of the outcomes. Conclusions: Health outcome descriptors are feasible and should be developed prior to the outcome prioritization step in the guideline development process. Guideline developers should involve a subgroup of multidisciplinary experts in all stages of development and ensure all guideline panel members are trained in guideline methodology that includes understanding the importance of defining and understanding the outcomes of interest.

BALDEH Tejan;  SAZ PARKINSON Zuleika Esther;  MUTI Paola;  SANTESSO Nancy;  MORGANO Gian Paolo;  WIERCIOCH Wojtek;  NIEUWLAAT Robby;  GRÄWINGHOLT Axel;  BROEDERS Mireille;  DUFFY Stephen;  HOFVIND Solveig;  NYSTROM Lennarth;  IOANNIDOU-MOUZAKA Lydia;  WARMAN Sue;  MCGARRIGLE Helen;  KNOX Susan;  FITZPATRICK Patricia;  GIORGI ROSSI Paolo;  QUINN Cecily;  BORISCH Bettina;  LEBEAU Annette;  DE WOLF Chris;  LANGENDAM Miranda;  PIGGOTT Thomas;  GIORDANO Livia;  VANLANDSVELD-VERHOEVEN Cary;  BERNIER Jacques;  RABE Peter;  SCHÜNEMANN Holger J.; 

2020-07-13

BMC

JRC112953

1477-7525 (online),   

https://hqlo.biomedcentral.com/articles/10.1186/s12955-020-01338-8,    https://publications.jrc.ec.europa.eu/repository/handle/JRC112953,   

10.1186/s12955-020-01338-8 (online),